Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. More Details
Outstanding track record, undervalued and pays a dividend.
Share Price & News
How has Vincent Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1612 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 1612's weekly volatility has decreased from 16% to 8% over the past year.
7 Day Return
HK Medical Equipment
1 Year Return
HK Medical Equipment
Return vs Industry: 1612 exceeded the Hong Kong Medical Equipment industry which returned 38.4% over the past year.
Return vs Market: 1612 exceeded the Hong Kong Market which returned 26.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Vincent Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall StVincent Medical Holdings Limited's (HKG:1612) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
2 weeks ago | Simply Wall StOne Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%
2 weeks ago | Simply Wall StVincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Is Vincent Medical Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 1612 (HK$1.61) is trading below our estimate of fair value (HK$9.46)
Significantly Below Fair Value: 1612 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 1612 is good value based on its PE Ratio (4.8x) compared to the HK Medical Equipment industry average (28x).
PE vs Market: 1612 is good value based on its PE Ratio (4.8x) compared to the Hong Kong market (11.7x).
Price to Earnings Growth Ratio
PEG Ratio: 1612's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: 1612 is good value based on its PB Ratio (1.7x) compared to the HK Medical Equipment industry average (3x).
How is Vincent Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1612's earnings are forecast to decline over the next 3 years (-11.1% per year).
Earnings vs Market: 1612's earnings are forecast to decline over the next 3 years (-11.1% per year).
High Growth Earnings: 1612's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 1612's revenue (3.4% per year) is forecast to grow slower than the Hong Kong market (13.3% per year).
High Growth Revenue: 1612's revenue (3.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1612's Return on Equity is forecast to be low in 3 years time (10.5%).
How has Vincent Medical Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1612 has high quality earnings.
Growing Profit Margin: 1612's current net profit margins (18.8%) are higher than last year (2.4%).
Past Earnings Growth Analysis
Earnings Trend: 1612's earnings have grown significantly by 30.8% per year over the past 5 years.
Accelerating Growth: 1612's earnings growth over the past year (1714.1%) exceeds its 5-year average (30.8% per year).
Earnings vs Industry: 1612 earnings growth over the past year (1714.1%) exceeded the Medical Equipment industry 19.7%.
Return on Equity
High ROE: 1612's Return on Equity (40.9%) is considered outstanding.
How is Vincent Medical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 1612's short term assets (HK$724.4M) exceed its short term liabilities (HK$330.9M).
Long Term Liabilities: 1612's short term assets (HK$724.4M) exceed its long term liabilities (HK$10.7M).
Debt to Equity History and Analysis
Debt Level: 1612's debt to equity ratio (11.4%) is considered satisfactory.
Reducing Debt: 1612's debt to equity ratio has increased from 2.2% to 11.4% over the past 5 years.
Debt Coverage: 1612's debt is well covered by operating cash flow (113.8%).
Interest Coverage: 1612's interest payments on its debt are well covered by EBIT (97x coverage).
What is Vincent Medical Holdings's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: 1612's dividend (6.83%) is higher than the bottom 25% of dividend payers in the Hong Kong market (1.96%).
High Dividend: 1612's dividend (6.83%) is in the top 25% of dividend payers in the Hong Kong market (6.02%)
Stability and Growth of Payments
Stable Dividend: 1612 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 1612's dividend payments have increased, but the company has only paid a dividend for 4 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (32.5%), 1612's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 1612's dividends in 3 years are forecast to be well covered by earnings (30.3% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Ki Cheung To (53 yo)
Mr. Ki Cheung To serves as Chief Executive Officer and General Manager at Vincent Medical Holdings Limited and has been its Executive Director November 2015. Mr. To is primarily responsible for overseeing ...
CEO Compensation Analysis
Compensation vs Market: Ki Cheung's total compensation ($USD228.47K) is about average for companies of similar size in the Hong Kong market ($USD232.75K).
Compensation vs Earnings: Ki Cheung's compensation has been consistent with company performance over the past year.
Experienced Board: 1612's board of directors are considered experienced (4.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2%.
Vincent Medical Holdings Limited's company bio, employee growth, exchange listings and data sources
- Name: Vincent Medical Holdings Limited
- Ticker: 1612
- Exchange: SEHK
- Founded: 1997
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$1.047b
- Shares outstanding: 650.60m
- Website: https://www.vincentmedical.com
Number of Employees
- Vincent Medical Holdings Limited
- Hang Fung Industrial Building
- Flat B2, 7th Floor, Phase 2
- Hung Hom
- Hong Kong
Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/14 10:28|
|End of Day Share Price||2021/04/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.